Found: 17
Select item for more details and to access through your institution.
In vitro inactivation of Chlamydia trachomatis and of a panel of DNA (HSV-2, CMV, adenovirus, BK virus) and RNA (RSV, enterovirus) viruses by the spermicide benzalkonium chloride.
- Published in:
- 2000
- By:
- Publication type:
- journal article
Quality of life in dermatology.
- Published in:
- International Journal of Dermatology, 2000, v. 39, n. 11, p. 801, doi. 10.1046/j.1365-4362.2000.00793.x
- By:
- Publication type:
- Article
Evaluation of the Pharmacokinetics and Renal Excretion of Simeprevir in Subjects with Renal Impairment.
- Published in:
- Drugs in R&D, 2015, v. 15, n. 3, p. 261, doi. 10.1007/s40268-015-0101-0
- By:
- Publication type:
- Article
Experience and impact of stigma in people with chronic hepatitis B: a qualitative study in Asia, Europe, and the United States.
- Published in:
- BMC Public Health, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12889-023-17263-6
- By:
- Publication type:
- Article
Hepatitis C Viral Evolution in Genotype 1 Treatment-Naïve and Treatment-Experienced Patients Receiving Telaprevir-Based Therapy in Clinical Trials.
- Published in:
- PLoS ONE, 2012, v. 7, n. 4, p. 1, doi. 10.1371/journal.pone.0034372
- By:
- Publication type:
- Article
Telaprevir Activity in Treatment-Naive Patients Infected Hepatitis C Virus Genotype 4: A Randomized Trial.
- Published in:
- Journal of Infectious Diseases, 2013, v. 208, n. 6, p. 1000, doi. 10.1093/infdis/jit274
- By:
- Publication type:
- Article
Clinical impact of pharmacokinetic interactions between the HCV protease inhibitor simeprevir and frequently used concomitant medications.
- Published in:
- British Journal of Clinical Pharmacology, 2018, v. 84, n. 5, p. 961, doi. 10.1111/bcp.13519
- By:
- Publication type:
- Article
Evolution of Treatment-Emergent Resistant Variants in Telaprevir Phase 3 Clinical Trials.
- Published in:
- Clinical Infectious Diseases, 2013, v. 57, n. 2, p. 221, doi. 10.1093/cid/cit226
- By:
- Publication type:
- Article
Simeprevir with peginterferon α-2a/ribavirin for chronic hepatitis C virus genotype 1 infection in treatment-experienced patients: an open-label, rollover study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Drug-Drug Interactions with the NS3/4A Protease Inhibitor Simeprevir.
- Published in:
- 2016
- By:
- Publication type:
- journal article
SimpliciTB RESULTS AND HEPATIC SAFETY OF PRETOMANID REGIMENS +/- PYRAZINAMIDE.
- Published in:
- Topics in Antiviral Medicine, 2023, v. 31, n. 2, p. 44
- By:
- Publication type:
- Article
Elucidating the Plasma and Liver Pharmacokinetics of Simeprevir in Special Populations Using Physiologically Based Pharmacokinetic Modelling.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Liver safety assessment in clinical trials of new agents for chronic hepatitis B.
- Published in:
- Journal of Viral Hepatitis, 2020, v. 27, n. 2, p. 96, doi. 10.1111/jvh.13223
- By:
- Publication type:
- Article
Veillonella Myositis in an Immunocompromised Patient.
- Published in:
- Clinical Infectious Diseases, 1995, v. 21, n. 3, p. 678, doi. 10.1093/clinids/21.3.678
- By:
- Publication type:
- Article
Virologic characterization of genotype 4 hepatitis C virus variants in patients treated with telaprevir.
- Published in:
- Virology Journal, 2014, v. 11, n. 1, p. 1, doi. 10.1186/1743-422X-11-93
- By:
- Publication type:
- Article
Fatigue during treatment for hepatitis C virus: results of self-reported fatigue severity in two Phase IIb studies of simeprevir treatment in patients with hepatitis C virus genotype 1 infection.
- Published in:
- BMC Infectious Diseases, 2014, v. 14, n. 1, p. 465, doi. 10.1186/1471-2334-14-465
- By:
- Publication type:
- Article
Simeprevir, daclatasvir, and sofosbuvir for hepatitis C virus-infected patients: Long-term follow-up results from the open-label, Phase II IMPACT study.
- Published in:
- Health Science Reports, 2020, v. 3, n. 2, p. 1, doi. 10.1002/hsr2.145
- By:
- Publication type:
- Article